Neurokinin-1 receptor antagonist aprepitant regulates autophagy and apoptosis via ROS/JNK in intrahepatic

Yang Yang1, Xueyan Cao1, Yuting Wang1

  • 1Institute of Digestive Endoscopy and Medical Center for Digestive Diseases, Second Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.

Abstract

Insights

Aprepitant shows cytotoxic effects on intrahepatic cholangiocarcinoma (iCCA) by inducing apoptosis and autophagy. This study investigates aprepitant

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Intrahepatic cholangiocarcinoma (iCCA) presents a poor prognosis with limited therapeutic strategies.
  • Aprepitant, a neurokinin-1 receptor (NK-1R) antagonist, exhibits anti-tumorigenic properties in various cancer models.
  • The potential of aprepitant in treating iCCA remains largely unexplored.

Purpose of the Study:

  • To investigate the expression of Substance P/NK-1R (SP/NK-1R) in iCCA.
  • To evaluate the cytotoxic effects of aprepitant on iCCA cells in vitro and in vivo.
  • To elucidate the underlying molecular mechanisms of aprepitant's action in iCCA.

Main Methods:

  • Immunohistochemistry was used to assess SP/NK-1R expression in clinical iCCA samples.
  • In vitro cytotoxicity was evaluated using MTT, EdU, and colony formation assays on iCCA cell lines (HCCC-9810, RBE).
  • In vivo efficacy was assessed using a subcutaneous xenograft mouse model, with mechanistic studies involving flow cytometry, western blotting, ROS detection, and JC-1 staining.

Main Results:

  • SP/NK-1R was significantly expressed in iCCA tissues.
  • Aprepitant demonstrated dose-dependent inhibition of iCCA cell viability and xenograft growth.
  • Aprepitant induced mitochondria-dependent apoptosis via the ROS/JNK pathway and triggered dynamic autophagosome changes.

Conclusions:

  • SP/NK-1R signaling is activated in iCCA and contributes to tumor proliferation.
  • Aprepitant effectively inhibits iCCA growth by inducing apoptosis and autophagy.
  • The mechanism involves ROS accumulation and subsequent JNK pathway activation.

Related Concept Videos

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates...
162
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.5K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.4K
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
3.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size...
11.4K